Abstract: Apparatuses, systems, and techniques to selectively use one or more neural network layers. In at least one embodiment, one or more neural network layers are selectively used based on, for example, one or more iteratively increasing neural network performance metrics.

Abstract: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: Disclosed are methods and devices for provisioning authorization claims, which are enforced to control access of users to objects (resources) in a computer system, and which are to be equivalent to an attribute-based access control (ABAC) policy. A policy converter according to the invention includes a policy processor processing the policy by partial evaluation against attribute values of the users, objects or permission levels in the system and outputting simplified policies, which are subject to reverse evaluation in a reverse policy evaluator, whereby users, objects and permission levels to be associated by way of a single authorization claim are obtained. Responsible for the defining of the authorization claim and its distribution in the computer system are an authorization claim generator and an authorization claim distribution interface. The invention may be so configured as to return a single authorization claim for each combination of an object and a permission level.

Abstract: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: Disclosed are methods and devices for provisioning authorization claims, which are enforced to control access of users to objects (resources) in a computer system, and which are to be equivalent to an attribute-based access control (ABAC) policy. A policy converter according to the invention includes a policy processor processing the policy by partial evaluation against attribute values of the users, objects or permission levels in the system and outputting simplified policies, which are subject to reverse evaluation in a reverse policy evaluator, whereby users, objects and permission levels to be associated by way of a single authorization claim are obtained. Responsible for the defining of the authorization claim and its distribution in the computer system are an authorization claim generator and an authorization claim distribution interface. The invention may be so configured as to return a single authorization claim for each combination of an object and a permission level.

Abstract: Disclosed are methods and devices for provisioning authorization claims, which are enforced to control access of users to objects (resources) in a computer system (330), and which are to be equivalent to an attribute-based access control (ABAC) policy. A policy converter according to the invention includes a policy processor (310) processing the policy by partial evaluation against attribute values of the users, objects or permission levels in the system and outputting simplified policies, which are subject to reverse evaluation in a reverse policy evaluator (320), whereby users, objects and permission levels to be associated by way of a single authorization claim are obtained. Responsible for the defining of the authorization claim and its distribution in the computer system are an authorization claim generator (330) and an authorization claim distribution interface (340). The invention may be so configured as to return a single authorization claim for each combination of an object and a permission level.

Abstract: A compound of an angiotensin receptor antagonist (ARB), a neutral endopeptidase inhibitor (NEPi) and one or more monovalent cations are useful for the treatment of hypertension and/or heart failure. ARB includes S—N-valeryl-N-{[2?-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine in the anion form, NEPi includes (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester in the anion form and cation includes monovalent cations such as Na+. The compound includes trisodium [3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3?-methyl-2?-(pentanoyl{2?-(tetrazol-5-ylate)biphenyl-4?-ylmethyl}amino)butyrate] hemipentahydrate.

Abstract: The invention relates to a new crystalline form of the acetate salt of which may be used, for example, for prevention or treatment of transplant rejection.

Abstract: The invention relates to compound of the formula I or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.

Abstract: Salts of benzimidazolyl pyridyl ethers are provided, particularly salts of {1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)amine. Compositions and formulations including such salts and surfactants as well as methods of preparing such compositions and formulations are provided.

Abstract: The invention provides acid addition salts of 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione, crystalline forms thereof, processes for the preparation thereof, pharmaceutical compositions comprising them and uses thereof in therapeutic treatment.

Abstract: Polymorphic forms of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide free base and salts thereof are prepared by various processes.

Abstract: Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide are prepared and characterized.

Abstract: Salts of N-hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2E-2-propenamide are prepared and characterized.

Abstract: The invention provides acid addition salts of 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione, crystalline forms thereof, processes for the preparation thereof, pharmaceutical compositions comprising them and uses thereof in therapeutic treatment.

Abstract: The invention relates to a new crystalline form of the acetate salt of, 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione, which may be used for example for transplantation.